- Home
- JANX vs DRD Comparison
JANX vs DRD Comparison
Compare JANX & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- DRD
- Stock Information
- Founded
- JANX 2017
- DRD 1895
- Country
- JANX United States
- DRD South Africa
- Employees
- JANX N/A
- DRD N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- DRD Precious Metals
- Sector
- JANX Health Care
- DRD Basic Materials
- Exchange
- JANX Nasdaq
- DRD Nasdaq
- Market Cap
- JANX 1.4B
- DRD 1.6B
- IPO Year
- JANX 2021
- DRD N/A
- Fundamental
- Price
- JANX $27.01
- DRD $25.67
- Analyst Decision
- JANX Strong Buy
- DRD Strong Buy
- Analyst Count
- JANX 11
- DRD 2
- Target Price
- JANX $76.55
- DRD $27.50
- AVG Volume (30 Days)
- JANX 927.5K
- DRD 814.0K
- Earning Date
- JANX 11-05-2025
- DRD 01-01-0001
- Dividend Yield
- JANX N/A
- DRD 1.79%
- EPS Growth
- JANX N/A
- DRD 68.66
- EPS
- JANX N/A
- DRD 1.46
- Revenue
- JANX $439,000.00
- DRD $443,674,785.00
- Revenue This Year
- JANX N/A
- DRD $10.81
- Revenue Next Year
- JANX $91.66
- DRD $20.03
- P/E Ratio
- JANX N/A
- DRD $19.97
- Revenue Growth
- JANX N/A
- DRD 26.26
- 52 Week Low
- JANX $21.73
- DRD $8.38
- 52 Week High
- JANX $71.71
- DRD $31.91
- Technical
- Relative Strength Index (RSI)
- JANX 59.54
- DRD 46.38
- Support Level
- JANX $25.62
- DRD $27.57
- Resistance Level
- JANX $27.70
- DRD $31.91
- Average True Range (ATR)
- JANX 1.56
- DRD 1.59
- MACD
- JANX 0.30
- DRD -0.60
- Stochastic Oscillator
- JANX 69.68
- DRD 9.36
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About DRD DRDGOLD Limited
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.